Stockscreener 앱 받기
5.095
3.32%
-0.175
시간 외 거래:
5.15
0.055
+1.08%
전일 마감가:
$5.27
열려 있는:
$5.37
하루 거래량:
2.80M
Relative Volume:
0.83
시가총액:
$834.78M
수익:
-
순이익/손실:
$-196.48M
주가수익비율:
-4.1907
EPS:
-1.2158
순현금흐름:
$-183.16M
1주 성능:
-2.39%
1개월 성능:
-10.77%
6개월 성능:
-18.35%
1년 성능:
+112.29%
1일 변동 폭
$5.025
$5.40
1주일 범위
$4.76
$5.40
52주 변동 폭
$2.03
$7.18
아넥손 Stock (ANNX) Company Profile
명칭
Annexon Inc
전화
(650) 822-5500
주소
1400 SIERRA POINT PARKWAY, BRISBANE
Compare ANNX vs VRTX, REGN, ARGX, RVMD, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ANNX
Annexon Inc
|
5.095 | 840.51M | 0 | -196.48M | -183.16M | -1.2158 |
VRTX
Vertex Pharmaceuticals Inc
|
477.10 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
762.63 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
853.82 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
187.53 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
316.01 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
아넥손 Stock (ANNX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-23 | 개시 | Chardan Capital Markets | Buy |
| 2024-03-01 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-12-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-10-30 | 개시 | Wells Fargo | Overweight |
| 2023-05-26 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-05-25 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-09-16 | 개시 | Jefferies | Buy |
| 2022-09-09 | 개시 | BTIG Research | Buy |
| 2021-11-30 | 개시 | H.C. Wainwright | Buy |
| 2021-09-23 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-01-26 | 개시 | Needham | Buy |
| 2020-08-18 | 개시 | BofA Securities | Buy |
| 2020-08-18 | 개시 | Cowen | Outperform |
| 2020-08-18 | 개시 | JP Morgan | Overweight |
모두보기
아넥손 주식(ANNX)의 최신 뉴스
BlackRock, Inc. (ANNX) reports 8.0% beneficial stake in Annexon common stock - Stock Titan
Annexon Inc (ANNX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
ANNX|Annexon Inc|Price:5.130|Chg%:-0.090 - TradingKey
Annexon Inc (ANNX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
ANNX|Annexon Inc|Price:5.200|Chg%:+0.070 - TradingKey
Annexon Inc (ANNX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Annexon Inc (ANNX) Institutional Confidence - TradingKey
Annexon Inc (ANNX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Annexon Inc (ANNX) Cash Flow - TradingKey
Annexon Inc (ANNX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Annexon Inc (ANNX) Income Statement - TradingKey
ANNX|Annexon Inc|Price:5.320|Chg%:+0.100 - TradingKey
Annexon Inc (ANNX) Balance Sheet - TradingKey
Breakthrough research in geographic atrophy advanced by Annexon at ASRS2026 - Traders Union
Annexon Inc (ANNX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Annexon Price Target Announced at $3.00/Share by Citizens - Moomoo
ANNX Initiates Coverage On by Citizens -- Rating Set to Market U - GuruFocus
Citizens JMP Initiates Annexon(ANNX.US) With Sell Rating, Announces Target Price $3 - Moomoo
Citizens initiates Annexon stock with underperform on GA trial concerns By Investing.com - Investing.com Canada
H.C. Wainwright Maintains Annexon(ANNX.US) With Buy Rating, Maintains Target Price $14 - Moomoo
H.C. Wainwright reiterates Buy on Annexon stock, $14 target By Investing.com - Investing.com Canada
Weekly Recap: ARCHER II enrollment completed and 335K options to two hires - TradingView
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) - Sahm
How Investors Are Reacting To Annexon (ANNX) Phase 3 Tanruprubart Win And Vonaprument Updates - Yahoo Finance
High Growth Tech Stocks To Watch In The US July 2026 - simplywall.st
Annexon grants new hires options for 335,000 shares at USD 6.5 each - Bitget
symbol__ Stock Quote Price and Forecast - CNN
Annexon (ANNX) filer Thomas Wiggans eyes 2,000-share NASDAQ stock sale - Stock Titan
Needham raises Annexon Biosciences stock price target to $25 on trial - Investing.com UK
Needham raises Annexon Biosciences stock price target to $25 on trial By Investing.com - Investing.com South Africa
Needham Maintains Annexon(ANNX.US) With Buy Rating, Raises Target Price to $25 - Moomoo
ANNX Maintained by Needham -- Price Target Raised to $25 - GuruFocus
FMR LLC's Strategic Acquisition of Annexon Inc Shares: A Detailed Analysis - GuruFocus
Annexon (ANNX) Presents Key Findings on Vision Preservation at A - GuruFocus
Annexon to present data on vonaprument for macular degeneration - Investing.com
Annexon to present data on vonaprument for macular degeneration By Investing.com - Investing.com Canada
Annexon to present Phase 2 ARCHER trial vision loss data for vonaprument at ASRS 2026 - Pluang
Annexon to Present Phase 2 ARCHER Baseline Characteristics Associated with Confirmed Best Corrected Visual Acuity 15-Letter Loss in Patients with Geographic Atrophy at ASRS 2026 - GlobeNewswire
Form 144 Annexon For: 14 July By Investing.com - Investing.com Nigeria
Annexon, Inc. SEC Filing (Jul 14, 2026) - Stock Titan
Annexon's tanruprubart shows strong Phase 3 res... - Pluang
Annexon: Perfect Complement To A Speculative Biotech Portfolio (NASDAQ:ANNX) - Seeking Alpha
Cantor Fitzgerald reiterates Overweight on Annexon stock By Investing.com - Investing.com Canada
Price to sales forward of Annexon, Inc. – NASDAQ:ANNX - TradingView
Price to book forward of Annexon, Inc. – NASDAQ:ANNX - TradingView
Enterprise value to revenue forward of Annexon, Inc. – NASDAQ:ANNX - TradingView
Enterprise value to EBITDA forward of Annexon, Inc. – BOATS:ANNX - TradingView
Price to earnings forward of Annexon, Inc. – NASDAQ:ANNX - TradingView
Annexon Inc. (ANNX) Slides 2.36% as Biotech Sector Faces HeadwindsPut Wall - dars.gov.et
Needham Maintains Annexon(ANNX.US) With Buy Rating, Maintains Target Price $11 - Moomoo
Redmile Group (ANNX) reports 9.9% stake; RedCo II Offshore at 5.5% - Stock Titan
아넥손 (ANNX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.44%
0.02%
자본화:
|
볼륨(24시간):